<!doctype html>																																																																																										<head><title>CG-MED-84 Non-Obstetric Gynecologic Duplex Ultrasonography of the Abdomen and Pelvis in the Outpatient Setting</title><meta http-equiv="Content-Type" content="text/html; charset=utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="xUDType" content="Medical_Guideline"><meta name="file" content=""><meta name="UDCategory" content="MED"><meta name="UDReference" content="CG-MED-84"><meta name="UDType" content="Medical_Guideline"><meta name="UDStatus" content="Current"> <meta name="mpStatus" content="Reviewed"><meta name="title" content="CG-MED-84"><meta name="xSortDate1" content="01/03/2024"><meta name="xSortPubTS" content="1704326399000"><meta name="date" content="01/03/2024"><link href="../../../css/cgmaster.css" rel="styleSheet" type="text/css" /><link href="../../../css/cgcommercial.css" rel="styleSheet" type="text/css" /> <script src="../../../js/adobeanalytics.js"></script>
<script>(window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch"}]);</script>
                              <script>!function(a){var e="https://s.go-mpulse.net/boomerang/",t="addEventListener";if("True"=="True")a.BOOMR_config=a.BOOMR_config||{},a.BOOMR_config.PageParams=a.BOOMR_config.PageParams||{},a.BOOMR_config.PageParams.pci=!0,e="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="YDDHU-FFACC-3AYXK-XQKBX-62T4Z",function(){function n(e){a.BOOMR_onload=e&&e.timeStamp||(new Date).getTime()}if(!a.BOOMR||!a.BOOMR.version&&!a.BOOMR.snippetExecuted){a.BOOMR=a.BOOMR||{},a.BOOMR.snippetExecuted=!0;var i,_,o,r=document.createElement("iframe");if(a[t])a[t]("load",n,!1);else if(a.attachEvent)a.attachEvent("onload",n);r.src="javascript:void(0)",r.title="",r.role="presentation",(r.frameElement||r).style.cssText="width:0;height:0;border:0;display:none;",o=document.getElementsByTagName("script")[0],o.parentNode.insertBefore(r,o);try{_=r.contentWindow.document}catch(O){i=document.domain,r.src="javascript:var d=document.open();d.domain='"+i+"';void(0);",_=r.contentWindow.document}_.open()._l=function(){var a=this.createElement("script");if(i)this.domain=i;a.id="boomr-if-as",a.src=e+"YDDHU-FFACC-3AYXK-XQKBX-62T4Z",BOOMR_lstart=(new Date).getTime(),this.body.appendChild(a)},_.write("<bo"+'dy onload="document._l();">'),_.close()}}(),"".length>0)if(a&&"performance"in a&&a.performance&&"function"==typeof a.performance.setResourceTimingBufferSize)a.performance.setResourceTimingBufferSize();!function(){if(BOOMR=a.BOOMR||{},BOOMR.plugins=BOOMR.plugins||{},!BOOMR.plugins.AK){var e=""=="true"?1:0,t="",n="wzdhuyixgvbdiztzidfq-f-0688a9d31-clientnsv4-s.akamaihd.net",i="false"=="true"?2:1,_={"ak.v":"37","ak.cp":"202149","ak.ai":parseInt("244874",10),"ak.ol":"0","ak.cr":33,"ak.ipv":4,"ak.proto":"http/1.1","ak.rid":"1552fac3","ak.r":36095,"ak.a2":e,"ak.m":"a","ak.n":"essl","ak.bpcip":"182.70.122.0","ak.cport":48778,"ak.gh":"23.210.93.68","ak.quicv":"","ak.tlsv":"tls1.3","ak.0rtt":"","ak.csrc":"-","ak.acc":"reno","ak.t":"1719222475","ak.ak":"hOBiQwZUYzCg5VSAfCLimQ==v6wYaMcVmMHhHQVrvvsjpv5P4TeWuRHWPofn4T8PyhmvOF/AyklQVv6L9je4SYrE4oLJtpCfzk+oqE0fMZ0ed5glqJy0qSVrzAoOSwRR4LQZgJdSwVwcdcza0MOfKDEX1e2UzIncpdaknoe9kPk9HB8SiEAoOu17DtSVM7OENhpqyEu9wmBUBnR5zEqjI/I+3BacKR+worKt128XWVddLAk/FSnAXoGUpstVQQmu07LchFr42Wdkz6X/W29nJMAK2O5FcxZpFw5e3/+gnc8n/6ugFHa0ySTUJcHhCkXMAtMBQFZc+yjOleViJZTklMNLerp8icacTthkQ25immx8y5yD/wK+gVsP6gnY9Z27nGZnhnF+QPctueSU/bpsEFt99C8ZbBvx+dJvesByx4+ExDaCdE5u7YMPkz85U73TCuw=","ak.pv":"490","ak.dpoabenc":"","ak.tf":i};if(""!==t)_["ak.ruds"]=t;var o={i:!1,av:function(e){var t="http.initiator";if(e&&(!e[t]||"spa_hard"===e[t]))_["ak.feo"]=void 0!==a.aFeoApplied?1:0,BOOMR.addVar(_)},rv:function(){var a=["ak.bpcip","ak.cport","ak.cr","ak.csrc","ak.gh","ak.ipv","ak.m","ak.n","ak.ol","ak.proto","ak.quicv","ak.tlsv","ak.0rtt","ak.r","ak.acc","ak.t","ak.tf"];BOOMR.removeVar(a)}};BOOMR.plugins.AK={akVars:_,akDNSPreFetchDomain:n,init:function(){if(!o.i){var a=BOOMR.subscribe;a("before_beacon",o.av,null,null),a("onbeacon",o.rv,null,null),o.i=!0}return this},is_complete:function(){return!0}}}}()}(window);</script><script >bazadebezolkohpepadr="1885181968"</script><script type="text/javascript" src="https://www.anthem.com/akam/13/705d9972"  defer></script></head><body><table> <tbody> <tr> <td><img class="logo_abc" src="../../images/abc.svg" /></td> <td id="policyTypeHeading">Clinical UM Guideline</td> </tr> </tbody> </table> <table id="docDetails"> <tbody> <tr> <td colspan="2"><strong>Subject:</strong> Non-Obstetric Gynecologic Duplex Ultrasonography of the Abdomen and Pelvis in the Outpatient Setting</td> </tr> <tr> <td width="75%"><strong>Guideline #:</strong> CG-MED-84</td> <td><strong>Publish Date:</strong> 01/03/2024</td> </tr> <tr> <td width="75%"><strong>Status:</strong> Reviewed</td> <td><strong>Last Review Date:</strong> 11/09/2023</td> </tr> </tbody> </table>  <table border="1" bordercolor="#000000" cellpadding="0" cellspacing="0" style="width:100%">	<tbody>		<tr>			<td class="head_stripe" width="100%"><strong>Description</strong></td>		</tr>	</tbody></table><p>This document addresses the use of duplex ultrasonography, in the outpatient, gynecologic setting, for the evaluation of conditions of the pelvis and surrounding tissues. A duplex ultrasound is a procedure used to visualize the pattern and direction of blood flow in arteries and veins via real-time images. This document does not address duplex ultrasonography for obstetric indications or infertility-related conditions and treatments.</p><p><strong>Note:</strong> Please see the following related document(s) for additional information:</p><ul>	<li><a href="../../../abc/active/guidelines/gl_pw_c159215.html"> CG-MED-42 Maternity Ultrasound in the Outpatient Setting</a></li>	<li><a href="../../../abc/active/guidelines/gl_pw_c195283.html"> CG-MED-56 Non-Obstetrical Transvaginal Ultrasonography</a></li></ul><table border="1" bordercolor="#000000" cellpadding="0" cellspacing="0" style="width:100%">	<tbody>		<tr>			<td class="head_stripe" width="100%"><strong>Clinical Indications</strong></td>		</tr>	</tbody></table><p><strong>Medically</strong><strong> Necessary:</strong></p><p>Non-obstetric, gynecologic, duplex ultrasonography of the abdomen or pelvis, in the outpatient setting, is considered <strong>medically necessary</strong> when there is a documented health history and physical examination findings that indicate visualization of vascular characteristics is necessary, including but not limited to evaluation or suspicion of the following conditions:</p><ol>	<li>Abnormal uterine bleeding; or</li>	<li>Endometrial polyps; or</li>	<li>Endometriomas; or</li>	<li>Neoplasm; or</li>	<li>Ovarian or adnexal cysts; or</li>	<li>Ovarian torsion; or</li>	<li>Pelvic congestion syndrome; or</li>	<li>Polycystic ovarian syndrome; or</li>	<li>Vascular diseases affecting the pelvic organs (for example, arteriovenous malformations and aneurysms).</li></ol><p><strong>Not Medically Necessary:</strong></p><p>Non-obstetric, gynecologic, duplex ultrasonography of the abdomen or pelvis, in the outpatient setting, is <strong>not medically necessary</strong> when the criteria above are not met and for all other indications, including but not limited to:</p><ol>	<li>Routine screening in asymptomatic individuals*;</li>	<li>Repeat evaluation in the absence of a change, or to assess a suspected change, in previously documented health exam findings.</li></ol><p>*The term &ldquo;individual&rdquo; in this document refers to any person with female reproductive and genitourinary systems, regardless of gender identity.</p><table border="1" bordercolor="#000000" cellpadding="0" cellspacing="0" style="width:100%">	<tbody>		<tr>			<td class="head_stripe" width="100%"><strong>Coding</strong></td>		</tr>	</tbody></table><p><em>The following codes for treatments and procedures applicable to this guideline are included below for informational purposes. Inclusion or exclusion of a procedure, diagnosis or device code(s) does not constitute or imply member coverage or provider reimbursement policy. Please refer to the member&#39;s contract benefits in effect at the time of service to determine coverage or non-coverage of these services as it applies to an individual member.</em></p><p style="text-align:justify"><strong>When services may be Medically Necessary when criteria are met:</strong></p><table cellspacing="0" class="Table" style="border-collapse:collapse; margin-left:15px; width:682px">	<tbody>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p style="text-align:justify"><strong>CPT</strong></p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>&nbsp;</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p style="text-align:justify">93975</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; complete study</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p style="text-align:justify">93976</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p style="text-align:justify">&nbsp;</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>&nbsp;</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p><strong>ICD-10 Diagnosis</strong></p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>&nbsp;</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>C51.0-C58</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Malignant neoplasms of the female genital organs</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>D07.0-D07.39</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Carcinoma in situ of endometrium, vulva, vagina, other and unspecified female genital organs</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>D26.0-D26.9</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Benign neoplasms of uterus</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>D27.0-D28.9</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Benign neoplasm of ovary, other and unspecified female genital organs</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>D39.0-D39.9</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Neoplasm of uncertain behavior of female genital organs</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>E28.2</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Polycystic ovarian syndrome</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>I72.8</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Aneurysm of other specified arteries [when specified as uterine or ovarian artery aneurysm]</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>I72.9</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Aneurysm of unspecified site [when specified as uterine or ovarian artery aneurysm]</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>N80.0-N80.9</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Endometriosis</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>N83.00-N83.299</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Ovarian cysts</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>N83.511-N83.53</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Torsion of ovary, ovarian pedicle and fallopian tube</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>N84.0</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Polyp of corpus uteri</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>N85.00-N85.02</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Endometrial hyperplasia</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>N91.0-N91.5</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Absent, scanty and rare menstruation</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>N92.0-N92.6</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Excessive, frequent and irregular menstruation</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>N93.0-N93.9</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Other abnormal uterine and vaginal bleeding</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>N94.89</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Other specified conditions associated with female genital organs and menstrual cycle [pelvic congestion syndrome]</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>N99.3</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Prolapse of vaginal vault after hysterectomy</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>Q27.39</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Arteriovenous malformation, other site [when specified as an arteriovenous malformation affecting the pelvic organs]</p>			</td>		</tr>	</tbody></table><p style="text-align:justify"><strong>When services are Not Medically Necessary:</strong><br />For the procedure and diagnosis codes listed above when criteria are not met, for situations designated in the Clinical Indications section as not medically necessary, or for the following diagnosis codes.</p><table cellspacing="0" class="Table" style="border-collapse:collapse; margin-left:15px; width:682px">	<tbody>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p><strong>ICD-10 Diagnosis</strong></p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>&nbsp;</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>Z01.411-Z01.419</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Encounter for routine gynecological examination</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:137px">			<p>Z12.73</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:545px">			<p>Screening for malignant neoplasm of ovary</p>			</td>		</tr>	</tbody></table><table border="1" bordercolor="#000000" cellpadding="0" cellspacing="0" style="width:100%">	<tbody>		<tr>			<td class="head_stripe" width="100%"><strong>Discussion/General Information</strong></td>		</tr>	</tbody></table><p>Ultrasonography (ultrasound [US]) generates sound waves that produce images of internal structures of the body to evaluate their form and function. Pelvic US may be performed using a transabdominal or transvaginal approach. A specialized type of US, duplex ultrasonography, combines 2-dimensional real-time imaging with Doppler flow analysis to visualize tissue movement and strain, and is particularly useful in evaluating arteries and veins in order to determine the pattern and direction of blood flow. The American Institute of Ultrasound in Medicine (AIUM) advocates for pelvic US as the first choice imaging modality in evaluation of the uterus and ovaries; however pelvic US &ldquo;should be performed only when there is a valid medical reason and the lowest possible ultrasonic exposure settings should be used to gain the necessary diagnostic information. In some cases, additional or specialized examinations [such as duplex scanning] may be necessary.&rdquo; While duplex ultrasound is relatively safe and readily available, its added value beyond a basic US is only realized in specific indications (AIUM, 2014).</p><p>In 2014, the AIUM in collaboration with the American College of Radiology (ACR), American College of Obstetricians and Gynecologists (ACOG), the Society of Pediatric Radiology (SPR), and the Society of Radiologists in Ultrasound (SRU) published a revised <em>Practice Parameter for the Performance of Ultrasound of the Female Pelvis </em>(AIUM, 2014). This practice parameter provides indications for pelvic ultrasonography. Non-obstetrical indications include, but are not limited to, evaluation of the following conditions: 1) pelvic pain, pelvic masses, or signs or symptoms of pelvic infection; 2) endocrine abnormalities (including polycystic ovaries); 3) amenorrhea, delayed menses, or dysmenorrhea (painful menses); 4) abnormal vaginal bleeding; 5) congenital uterine and lower genital tract anomalies; 6) postoperative pelvic surgery complications (such as excessive bleeding, pain, or signs of infection); or 7) incontinence or pelvic organ prolapse. Other recommendations for non-obstetrical US of the pelvis include: 1) follow-up of a previously detected abnormality; 2) further characterization of a pelvic abnormality noted on another imaging study; 3) guidance for interventional or surgical procedures; 4) localization of an intrauterine contraceptive device; 5) preoperative and postoperative evaluation of pelvic structures; and, 6) screening for malignancy in high-risk individuals. The guideline further states, &ldquo;Spectral, color, and/or power Doppler ultrasound <em>may</em> be useful to evaluate the vascular characteristics of pelvic lesions.&rdquo; Thus, the aforementioned indications do not routinely necessitate the addition of Doppler flow analysis to adequately assess conditions of the female pelvis, unless further characterization of blood is required to evaluate signs or symptoms or aid in diagnosis of a condition.</p><p>In a prospective trial investigating 55 individuals diagnosed with polycystic ovarian syndrome (PCOS), and matched controls who did not have a diagnosis of PCOS, ovarian stromal artery pulsatility index (PI) was inversely correlated with the luteinizing hormone/follicle-stimulating hormone ratio. Authors concluded that the addition of Doppler analysis may provide additional information regarding the etiology of PCOS in affected individuals (Adali, 2009).</p><p>Aleem and colleagues conducted a prospective analysis of 20 individuals with suspected endometriosis. A total of 24 masses were identified, 16 of which were confirmed endometriomas. A total of 11 out of 16 (69%) of endometriomas showed flow by Doppler. The authors concluded that scattered vascularity, as seen by Doppler imaging, may help differentiate adnexal endometriomas from other lesions of dense vascular distribution, such as ovarian neoplasms or corpora lutea (Aleem, 1995). Another small, retrospective study, also found that blood flow characteristics, as seen by Doppler ultrasound, revealed vascularization of ovarian endometriomas was higher in individuals presenting with pelvic pain than in those who are asymptomatic (Alcazar, 2001).</p><p>In a prospective study of 84 individuals with confirmed adnexal masses, 44 were determined to be benign and 40 were malignant. Authors refer to Doppler as the mainstay in diagnosis of ovarian tumors and determined from this study, the specificity and sensitivity of Doppler in differentiating between malignant and benign ovarian tumors, was 84.1% and 97.5%, respectively (Shah, 2013).</p><p>The clinical utility of duplex ultrasonography of the abdomen or pelvis has been evaluated for a number of non-obstetric, gynecologic conditions, including, but not limited to assessing vascular characteristics associated with: endometrioses, uterine lesions and neoplasms, ovarian or adnexal cysts, ovarian torsion, pelvic congestion syndrome, PCOS, and vascular diseases affecting the uterus (for example, arteriovenous malformations and aneurysms) (Adali, 2009; Alc&aacute;zar , 2001; Aleem, 1995; Bhosale, 2016; Expert Panel on Women&rsquo;s Imaging, 2019; He, 2020; Ludovisi, 2019; Shah, 2013; Steenbeek, 2018; Virgilio, 2019). While use of duplex ultrasonography in evaluating some of the aforementioned conditions is not routinely recommended (e.g., PCOS, ovarian torsion and endometriomas), studies have shown clinical utility in select cases where it may aid in differentiating between gynecologic conditions that present with distinct blood flow patterns.</p><table border="1" bordercolor="#000000" cellpadding="0" cellspacing="0" style="width:100%">	<tbody>		<tr>			<td class="head_stripe" width="100%"><strong>Definitions</strong></td>		</tr>	</tbody></table><p>Doppler ultrasound: An exam that measures blood flow through your arteries and veins.</p><p>Transabdominal: Through or across the abdomen.</p><p>Transvaginal: Through the vagina.</p><table border="1" bordercolor="#000000" cellpadding="0" cellspacing="0" style="width:100%">	<tbody>		<tr>			<td class="head_stripe" width="100%"><strong>References</strong></td>		</tr>	</tbody></table><p><strong>Peer Reviewed Publications:</strong></p><ol>	<li>Adali E, Kolusari A, Adali F, et al. Doppler analysis of uterine perfusion and ovarian stromal blood flow in polycystic ovary syndrome. Int J Gynaecol Obstet. 2009; 105(2):154-157.</li>	<li>Alc&aacute;zar JL. Transvaginal colour Doppler in patients with ovarian endometriomas and pelvic pain. Hum Reprod. 2001; 16(12):2672-2675.</li>	<li>Aleem F, Pennisi J, Zeitoun K, Predanic M. The role of color Doppler in diagnosis of endometriomas. Ultrasound Obstet Gynecol. 1995; 5(1):51-54.</li>	<li>Ludovisi M, Moro F, Pasciuto T, et al. Imaging in gynecological disease (15): clinical&thinsp;and&thinsp;ultrasound characteristics of uterine sarcoma. Ultrasound Obstet Gynecol. 2019; 54(5):676-687.</li>	<li>He M, Hu S, Luo H. Ultrasound diagnosis and clinicopathological traits of female genital system malignant lymphomas. Medicine (Baltimore). 2020; 99(34):e21341.</li>	<li>Shah D, Shah S, Parikh J, et al. Doppler ultrasound: a good and reliable predictor of ovarian malignancy. J Obstet Gynaecol India. 2013; 63(3):186-189.</li>	<li>Steenbeek MP, van der Vleuten CJM, Schultze Kool LJ, Nieboer TE. Noninvasive diagnostic tools for pelvic congestion syndrome: a systematic review. Acta Obstet Gynecol Scand. 2018; 97(7):776-786.</li>	<li>Virgilio BA, De Blasis I, Sladkevicius P, et al. Imaging in gynecological disease (16): clinical and ultrasound characteristics of serous cystadenofibromas in adnexa. Ultrasound Obstet Gynecol. 2019; 54(6):823-830.</li></ol><p><strong>Government Agency, Medical Society, and Other Authoritative Publications:</strong></p><ol>	<li>American College of Radiology (ACR), American College of Obstetrics and Gynecology (ACOG), American Institute of Ultrasound in Medicine (AIUM), and Society of Pediatric Radiology (SPR). ACR&ndash;ACOG&ndash;AIUM&ndash;SRU practice parameter for the performance of ultrasound of the female pelvis. 2019. Available at: <a href="https://www.acr.org/-/media/ACR/Files/Practice-Parameters/us-pelvis.pdf?la=en" style="color:blue; text-decoration:underline">https://www.acr.org/-/media/ACR/Files/Practice-Parameters/us-pelvis.pdf?la=en</a>. Accessed on October 08, 2023.</li>	<li>American College of Radiology (ACR), American College of Obstetrics and Gynecology (ACOG), American Institute of Ultrasound in Medicine (AIUM), and Society of Pediatric Radiology (SPR). ACR&ndash;AIUM&ndash;SPR&ndash;SRU practice parameter for the performance of an ultrasound examination of the abdomen and/or retroperitoneum. 2017. Available at: <a href="https://www.acr.org/-/media/ACR/Files/Practice-Parameters/us-abd-retro.pdf?la=en" style="color:blue; text-decoration:underline">https://www.acr.org/-/media/ACR/Files/Practice-Parameters/us-abd-retro.pdf?la=en</a>. Accessed on October 08, 2023.</li>	<li>Bhosale PR, Javitt MC, Atri M, et al. ACR Appropriateness Criteria<sup>&reg;</sup> Acute pelvic pain in the reproductive age group. Ultrasound Q. 2016; 32(2):108-115.</li>	<li>Expert Panel on Women&rsquo;s Imaging:&nbsp;Atri M, Alabousi A, et al. ACR Appropriateness Criteria<sup>&reg;</sup> Clinically suspected adnexal mass, no acute symptoms. J Am Coll Radiol. 2019; 16(5S):S77-S93.</li></ol><table border="1" bordercolor="#000000" cellpadding="0" cellspacing="0" style="width:100%">	<tbody>		<tr>			<td class="head_stripe" width="100%"><strong>History</strong></td>		</tr>	</tbody></table><table cellspacing="0" class="Table" style="border-collapse:collapse; margin-left:7px; width:682px">	<tbody>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:90px">			<p><strong>Status</strong></p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:101px">			<p><strong>Date</strong></p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:491px">			<p><strong>Action</strong></p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:90px">			<p>Reviewed</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:101px">			<p>11/09/2023</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:491px">			<p>Medical Policy &amp; Technology Assessment Committee (MPTAC) review. Updated References section.</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:90px">			<p>Reviewed</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:101px">			<p>11/10/2022</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:491px">			<p>MPTAC review. Updated References section.</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:90px">			<p>Reviewed</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:101px">			<p>11/11/2021</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:491px">			<p>MPTAC review. Updated References section.</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:90px">			<p>Reviewed</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:101px">			<p>11/05/2020</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:491px">			<p>MPTAC review. Updated Background/Overview and References sections. Reformatted Coding section to include additional diagnosis codes.</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:90px">			<p>Revised</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:101px">			<p>11/07/2019</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:491px">			<p>MPTAC review. Clarified MN statements. Updated Background/Overview, Coding and References sections.</p>			</td>		</tr>		<tr>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:90px">			<p>New</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:101px">			<p>08/22/2019</p>			</td>			<td style="padding:0in 7px 0in 7px; vertical-align:top; width:491px">			<p>MPTAC review. Initial document development.</p>			</td>		</tr>	</tbody></table><hr /><p>Federal and State law, as well as contract language, and Medical Policy take precedence over Clinical UM Guidelines. We reserve the right to review and update Clinical UM Guidelines periodically. Clinical guidelines approved by the Medical Policy &amp; Technology Assessment Committee are available for general adoption by plans or lines of business for consistent review of the medical necessity of services related to the clinical guideline when the plan performs utilization review for the subject. Due to variances in utilization patterns, each plan may choose whether to adopt a particular Clinical UM Guideline. To determine if review is required for this Clinical UM Guideline, please contact the customer service number on the member&#39;s card.</p><p>Alternatively, commercial or FEP plans or lines of business which determine there is not a need to adopt the guideline to review services generally across all providers delivering services to Plan&rsquo;s or line of business&rsquo;s members may instead use the clinical guideline for provider education and/or to review the medical necessity of services for any provider who has been notified that his/her/its claims will be reviewed for medical necessity due to billing practices or claims that are not consistent with other providers, in terms of frequency or in some other manner.</p><p>No part of this publication may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic, mechanical, photocopying, or otherwise, without permission from the health plan.</p><p>&copy; CPT Only - American Medical Association</p><noscript><img src="https://www.anthem.com/akam/13/pixel_705d9972?a=dD02ZDg4OGQ2YzM5NmU3NGQxMjQzMmRjOTNjOGJlMzhmZWQxZmI0Zjc0JmpzPW9mZg==" style="visibility: hidden; position: absolute; left: -999px; top: -999px;" /></noscript><script type="text/javascript"  src="/iOP-/eY9D/A/kZ/IVzY-qg/OuYDVXwhtJ/aioOJQUXBw/JwpDFiM/2Xh4"></script></body>			</html>